- £171.52bn
- £189.74bn
- $45.81bn
- 73
- 15
- 57
- 44
REG - AstraZeneca PLC - Imfinzi improved survival in biliary tract cancer
AnnouncementREG - AstraZeneca PLC - AZ recommends ADS holders reject mini-tender offer
AnnouncementREG - AstraZeneca PLC - Imfinzi & tremelimumab improved OS in liver cancer
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - AZD7442 PhIII trial positive in COVID outpatients
AnnouncementREG - AstraZeneca PLC - Enhertu granted BTD for breast cancer
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca to fully acquire Caelum Biosciences
AnnouncementREG - AstraZeneca PLC - Saphnelo approved in Japan for SLE
AnnouncementREG - AstraZeneca PLC - Lynparza PROpel trial meets primary endpoint
AnnouncementREG - AstraZeneca PLC - New Sustainability Committee of the Board
AnnouncementREG - AstraZeneca PLC - Board Committee Change
AnnouncementREG - AstraZeneca PLC - AstraZeneca $360m Irish manufacturing investment
AnnouncementREG - AstraZeneca PLC - Enhertu reduced risk of disease progression by 72%
AnnouncementREG - AstraZeneca PLC - Imfinzi improves survival in NSCLC in POSEIDON
AnnouncementREG - AstraZeneca PLC - PT027 PhIII asthma trials met primary endpoints
AnnouncementREG - AstraZeneca PLC - Ultomiris approved in EU for children with PNH
AnnouncementREG - Schiehallion Fund Schiehallion - MNTN Schiehallion - MNTC - Directorate Change
Announcement